Clinical Trial Update: MoCa Test for the Early Detection of Mild Cognitive Impairment During Annual Assessment of Young Adults With Diabetes and in a Control Group Without Diabetes [NA]

View source ↗

Summary

This clinical trial update evaluates the use of the Montreal Cognitive Assessment (MoCA) to detect mild cognitive impairment during annual assessments of young …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Clalit Health Services | Conditions: Diabetes Mellitus Type 1, Diabetes Mellitus Type 2 | NA | Status: UNKNOWN